Euclidean Capital LLC
- SEC CIK
- 0001825034
- Latest filing
- Aug 14, 2026
Holdings in Q4 2021
Holdings as of Dec 31, 2021, filed Feb 14, 2022. Long positions only; changes compare share counts with Q3 2021.
- Positions
- 11
- +1 vs. Q3 2021
- Portfolio value
- $175.9M
- −$29.8M (−14.5%) vs. Q3 2021
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| PMVPPMV Pharmaceuticals, Inc. | COM | 2,336,909 | $54.0M | 30.7% | −432,904−15.6% | Reduced | History |
| FHTXFoghorn Therapeutics Inc. | COM | 1,261,261 | $28.8M | 16.4% | 00.0% | Unchanged | History |
| ALECAlector, Inc. | COM | 980,894 | $20.3M | 11.5% | 00.0% | Unchanged | History |
| TNYATenaya Therapeutics, Inc. | COM | 915,705 | $17.4M | 9.9% | 00.0% | Unchanged | History |
| RAPTRAPT Therapeutics, Inc. | COM | 432,900 | $15.9M | 9.0% | −202,277−31.8% | Reduced | History |
| NGMNGM Biopharmaceuticals Inc | COM | 746,674 | $13.2M | 7.5% | −85,600−10.3% | Reduced | History |
| ORICOric Pharmaceuticals, Inc. | COM | 747,550 | $11.0M | 6.2% | −29,643−3.8% | Reduced | History |
| SRZNSurrozen, Inc. | COM | 802,964 | $5.17M | 2.9% | −10.0% | Reduced | History |
| MQMarqeta, Inc. | CLASS A COM | 247,752 | $4.25M | 2.4% | +247,752 | New | History |
| FFBCFirst Financial Bancorp | COM | 173,576 | $4.23M | 2.4% | 00.0% | Unchanged | History |
| VIRVir Biotechnology, Inc. | COM | 40,257 | $1.69M | 1.0% | +40,257 | New | History |
Sold out since Q3 2021 (1)
Positions held at the end of Q3 2021 that are gone from this filing.